RGD Reference Report - DNMT3B polymorphisms and risk of primary lung cancer. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

DNMT3B polymorphisms and risk of primary lung cancer.

Authors: Lee, SJ  Jeon, HS  Jang, JS  Park, SH  Lee, GY  Lee, BH  Kim, CH  Kang, YM  Lee, WK  Kam, S  Park, RW  Kim, IS  Cho, YL  Jung, TH  Park, JY 
Citation: Lee SJ, etal., Carcinogenesis. 2005 Feb;26(2):403-9. Epub 2004 Nov 4.
RGD ID: 9589086
Pubmed: PMID:15528220   (View Abstract at PubMed)
DOI: DOI:10.1093/carcin/bgh307   (Journal Full-text)

DNA-methyltransferase-3B (DNMT3B) plays an important role in the generation of aberrant methylation in carcinogenesis. Polymorphisms and haplotypes of the DNMT3B gene may influence DNMT3B activity on DNA methylation, thereby modulating the susceptibility to lung cancer. To test this hypothesis, we investigated the association of the -283T > C (from exon 1A transcription start site) and -579G > T (from exon 1B transcription start site) polymorphisms in DNMT3B promoter, and their haplotypes with the risk of lung cancer in a Korean population. The DNMT3B genotype was determined in 432 lung cancer patients and 432 healthy controls that were frequency-matched for age and sex. Individuals with at least one -283T allele were at a significantly decreased risk of adenocarcinoma (AC) and small cell carcinoma (SM) [adjusted odds ratio (OR) = 0.48, 95% confidence interval (CI) = 0.28-0.82, P = 0.007; and adjusted OR = 0.47, 95% CI = 0.24-0.93, P = 0.03, respectively] compared with those harboring a -283CC genotype. Individuals with at least one -579G allele were also at a significantly decreased risk of AC and SM (adjusted OR = 0.47, 95% CI = 0.28-0.81, P = 0.006; and adjusted OR = 0.51, 95% CI = 0.26-0.99, P = 0.048, respectively) compared with those having a -579TT genotype. The -283T allele was linked with the -579G allele, and haplotype -283T/-579G was associated with a significantly decreased risk of AC (adjusted OR = 0.48, 95% CI = 0.29-0.81, P = 0.006) as compared with haplotype -283C/-579T. In a promoter assay, carriage of the -283T allele showed a significantly lower promoter activity ( approximately 50%) compared with the -283C allele (P < 0.001), but the -579G > T polymorphism did not have an affect on the DNMT3B promoter activity. These results suggest that the DNMT3B -283T > C polymorphism influences DNMT3B expression, thus contributing to the genetic susceptibility to lung cancer.

RGD Manual Disease Annotations    Click to see Annotation Detail View
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
lung adenocarcinoma susceptibilityIAGP 9589086DNA:SNPs more ...RGD 
lung adenocarcinoma susceptibilityISODNMT3B (Homo sapiens)9589086; 9589086DNA:SNPs more ...RGD 
lung small cell carcinoma susceptibilityIAGP 9589086DNA:SNPs:promoter:-283T >C and -579G>T(human)RGD 
lung small cell carcinoma susceptibilityISODNMT3B (Homo sapiens)9589086; 9589086DNA:SNPs:promoter:-283T >C and -579G>T(human)RGD 

Objects Annotated

Genes (Rattus norvegicus)
Dnmt3b  (DNA methyltransferase 3 beta)

Genes (Mus musculus)
Dnmt3b  (DNA methyltransferase 3B)

Genes (Homo sapiens)
DNMT3B  (DNA methyltransferase 3 beta)


Additional Information